Thermo Fisher Scientific (Hong Kong) Limited
赛默飞世尔科技(香港)有限公司
Hong Kong MDACS34 represented devices10 applicantsFeb 10, 2021 – Sep 24, 2024
VerifiedMDD (Medical Device Division) · MDACS registry
34
Total devices
10
Applicants
2021
First representation
2024
Most recent
AR overview
- Authorised representative (EN)
- Thermo Fisher Scientific (Hong Kong) Limited
- Authorised representative (ZH)
- 赛默飞世尔科技(香港)有限公司
- Phone
- 31077600
Timeline
- First representation
- Feb 10, 2021
- Most recent
- Sep 24, 2024
Regulatory footprint
Search Thermo Fisher Scientific (Hong Kong) Limited across other regulatory registries
Risk class distribution
B27
C5
II2
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by Thermo Fisher Scientific (Hong Kong) Limited
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Sep 24, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Molecular Assay, Control, Targeted Sequencing, Human
体外诊断检测试剂/试剂盒, 分子检测, 对照, 靶向测序, 人类
Sep 11, 2024
- Risk class
- C
- Applicant
- Microgenics CorporationMicrogenics Corporation
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Aug 29, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin A
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白A
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin M
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 M
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin A
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白A
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin A
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白A
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin M
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 M
Aug 16, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Clinical Chemistry, Alcohol Level
体外诊断检测试剂/试剂盒、临床化学、酒精含量
Aug 08, 2024
- Risk class
- B
- Applicant
- Microgenics CorporationMicrogenics Corporation
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin A
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白A
Jul 23, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin A
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白A
Jul 23, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
IVD Test Reagent/Kits, Immunoassay, Protein, Immunoglobulin G
体外诊断 测试试剂/试剂盒、免疫测定、蛋白质、免疫球蛋白 G
Jul 23, 2024
- Risk class
- B
- Applicant
- PHADIA ABPhadia Ab
About this profile
Thermo Fisher Scientific (Hong Kong) Limited serves as the authorised representative for 34 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.